Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis-Reference-Cited by-同舟云学术

Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis

Published:2011-04 Issue:4 Volume:10 Page:329-337
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Giovannoni Gavin,Cook Stuart,Rammohan Kottil,Rieckmann Peter,Sørensen Per Soelberg,Vermersch Patrick,Hamlett Anthony,Viglietta Vissia,Greenberg Steven

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference36 articles.

1. Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach;Sormani;Ann Neurol,2009

2. Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study;Havrdova;Lancet Neurol,2009

3. Freedom from disease activity in multiple sclerosis;Havrdova;Neurology,2010

4. Cladribine: mode of action and implications for treatment of multiple sclerosis;Leist;Clin Neuropharmacol,2011

5. The role of CD4 T cells in the pathogenesis of multiple sclerosis;Chitnis;Int Rev Neurobiol,2007

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of therapy satisfaction with cladribine tablets in patients with RMS: Final results of the non-interventional study CLEVER;Multiple Sclerosis and Related Disorders;2024-10

2. Early clinical effect of cladribine in patients with highly active multiple sclerosis in Mexico;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2024-07

3. Clinicoradiological Factors for Predicting and Monitoring the Progression of Multiple Sclerosis;Journal of Multiple Sclerosis and Neuroimmunology;2024-06-30

4. Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra;Neurology, Neuropsychiatry, Psychosomatics;2024-06-22

5. As time goes by: Treatment challenges in elderly people with multiple sclerosis;Journal of Neuroimmunology;2024-06